Acasti Pharma's market cap is currently ―. The company's EPS TTM is $-5.094; its P/E ratio is -0.57; Acasti Pharma is scheduled to report earnings on June 18, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -2.60M	$ -3.72M	$ -4.31M	$ -37.96M	$ -4.16M
EBITDA	$ -2.60M	$ -3.72M	$ -4.30M	$ -37.95M	$ -4.15M
Net Income Common Stockholders	$ -2.39M	$ -3.27M	$ -4.02M	$ -29.09M	$ -3.89M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 25.11M	$ 27.01M	$ 21.65M	$ 27.89M	$ 31.26M
Total Assets	$ 76.19M	$ 78.21M	$ 73.03M	$ 79.12M	$ 116.80M
Total Debt	$ 24.00K	$ 46.00K	$ 80.00K	$ 485.00K	$ 503.00K
Net Debt	$ -25.09M	$ -26.96M	$ -21.57M	$ -27.41M	$ -30.75M
Total Liabilities	$ 11.51M	$ 11.46M	$ 9.02M	$ 11.17M	$ 20.08M
Stockholders Equity	$ 64.68M	$ 66.75M	$ 64.01M	$ 67.95M	$ 96.72M
Cash Flow	-
Free Cash Flow	-	$ -2.00M	$ -6.24M	$ -3.33M	$ -3.72M
Operating Cash Flow	-	$ -2.11M	$ -6.24M	$ -3.33M	$ -3.72M
Investing Cash Flow	-	$ 110.00K	-	$ 4.99M	$ -5.00M
Financing Cash Flow	-	$ 7.36M	-	-	-

Currency in USD

Acasti Pharma Earnings and Revenue History

Income Statement >

Acasti Pharma Debt to Assets

Balance Sheet >

Acasti Pharma Cash Flow

Cash Flow >

Acasti Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing